Metformina + Sitagliptina Pharmazac 50 Mg/850 Mg

Metformin, the active ingredient in Metformina + Sitagliptina Pharmazac 50 Mg/850 Mg, is a biguanide presented as a 850 mg/50 mg tablet for oral use. It treats type 2 diabetes mellitus in adult patients. GNH USA supplies Metformina + Sitagliptina Pharmazac 50 Mg/850 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina + Sitagliptina Pharmazac is an oral antidiabetic medication used to manage blood glucose in type 2 diabetes. - Type 2 diabetes mellitus: improves glycaemic control when diet, exercise, and monotherapy are insufficient. - Inadequate control on metformin alone: provides additional glucose‑lowering effect as part of combination therapy. - Adults with hyperglycaemia: helps achieve target fasting and post‑prandial glucose levels.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, especially during treatment initiation. - Abdominal discomfort: cramping or pain. - Headache: transient tension‑type headache. - Upper respiratory tract infection: mild cold‑like symptoms. - Hypoglycaemia (when combined with sulfonylureas): low blood sugar episodes.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe allergic reactions: rash, angioedema, or anaphylaxis. - Pancreatitis: acute inflammation of the pancreas. - Hepatic failure: signs of liver dysfunction. - Stevens‑Johnson syndrome: severe skin reaction. - Persistent vomiting: may indicate serious gastrointestinal issue.

Before initiating therapy, consider the following precautions: - Renal function: assess eGFR and avoid use in severe renal impairment. - Hepatic disease: use with caution in patients with liver dysfunction. - Risk of lactic acidosis: monitor for symptoms in patients with conditions predisposing to hypoxia. - Pregnancy and lactation: safety not established; consult a healthcare professional. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Metformina + Sitagliptina Pharmazac may interact with several medicines. Major Interactions (Avoid): - Phenformin: co‑administration increases risk of lactic acidosis. - IV contrast agents in patients with renal impairment: may precipitate renal failure. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise sitagliptin plasma levels. Moderate Interactions (Monitor Closely): - Sulfonylureas: heightened risk of hypoglycaemia. - Diuretics: may affect renal clearance of metformin. - Alcohol: can increase the likelihood of lactic acidosis.